The development of highly efficient electrocatalysts to reduce overpotentials is vital for accelerating the sluggish oxygen evolution reaction (OER) processes. Herein, we demonstrate ultrathin heterogeneous nanosheets as a promising OER electrocatalyst, which are composed of ultrafine CoFeO nanoparticles and a monolayered CoN-based metal-organic framework (MOF) matrix. The embedding of such inorganic nanoparticles in the MOF lattice creates metal Co sites located at the CoFeO/MOF interfaces. Structural characterization and analysis indicated a higher valence and changed 3d electronic configuration for the interfacial Co in contrast to the CoN sites. Furthermore, theoretical calculations reveal the high activity of interfacial Co sites for OER. Electrochemical studies confirm that the ultrathin heterogeneous nanosheets deposited on carbon cloth can achieve an excellent electrocatalytic OER performance with a low overpotential of 232 mV at a current density of 10 mA cm with good stability. This work provides insights on the development of ultrathin OER heterocatalysts with highly active interfaces of inorganic units and MOFs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsnano.9b08458 | DOI Listing |
ACS Biomater Sci Eng
January 2025
Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3E3, Canada.
Restenosis remains a long-standing limitation to effectively maintain functional blood flow after percutaneous transluminal angioplasty (PTA). While the use of drug-coated balloons (DCBs) containing antiproliferative drugs has improved patient outcomes, limited tissue transfer and poor therapeutic targeting capabilities contribute to off-target cytotoxicity, precluding adequate endothelial repair. In this work, a DCB system was designed and tested to achieve defined arterial delivery of an antirestenosis therapeutic candidate, cadherin-2 (N-cadherin) mimetic peptides (NCad), shown to selectively inhibit smooth muscle cell migration and limit intimal thickening in early animal PTA models.
View Article and Find Full Text PDFMicrosyst Nanoeng
January 2025
State Key Laboratory of Explosion Science and Safety Protection, Beijing Institute of Technology, Ministry of Education, 100081, Beijing, China.
Recently, the biologically inspired intelligent artificial visual neural system has aroused enormous interest. However, there are still significant obstacles in pursuing large-scale parallel and efficient visual memory and recognition. In this study, we demonstrate a 28 × 28 synaptic devices array for the artificial visual neuromorphic system, within the size of 0.
View Article and Find Full Text PDFJ Vis Exp
December 2024
Department of Cell Biology, School of Life Sciences, Central South University;
The aqueous extract from the bark of Eucommia ulmoides serves as a rich source of bioactive compounds with numerous health benefits. The protocol here aims to explore the preparation of zinc oxide (ZnO) nanoparticles using the Eucommia ulmoides bark-mediated polyisoprene-rich aqueous extract. Meanwhile, the proposed protocol is associated with the preparation of wound healing material by easing the process.
View Article and Find Full Text PDFInt J Nanomedicine
January 2025
Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
Purpose: Dimethyl fumarate (DMF), the first-line oral therapy for relapsing-remitting multiple sclerosis, is rapidly metabolized into monomethyl fumarate. The DMF oral administration provokes gastrointestinal discomfort causing treatment withdrawal. The present study aimed to develop an innovative formulation for DMF nasal administration.
View Article and Find Full Text PDFJ Control Release
January 2025
Precision Medicine in Oncology (PrMiO), and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands. Electronic address:
The recent approval of pembrolizumab in recurrent or metastatic cervical cancer warrants further investigations into the usefulness of immunotherapies for more durable and less radical interventions. In this study, the targeting potential of anti-PD-L1-functionalized immunoliposomes was tested in a 3D in vitro cervical cancer-on-a-chip model. Immunolipsomes were synthesized and decorated externally with monovalent anti-PD-L1 Fab' fragments of commercially available atezolizumab.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!